1.55
price down icon3.73%   -0.06
 
loading

Finanzdaten der Ikena Oncology Inc-Aktie (IKNA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
100.00%
-
0.659 1.185 2.004 5.313
Operating Expenses
19.24%
18.23
22.57 20.69 20.49 20.83
Operating Income/Loss
16.81%
-18.23
-21.91 -19.50 -18.49 -15.52
Nonoperating Income/Loss
2.107
- 2.16 1.375 1.296
Income/Loss From Continuing Operations Before Tax
17.97%
-16.12
-19.65 1.185 -17.11 -14.22
Income Tax Expense/Benefit
0.027
- - - -
Income/Loss From Continuing Operations After Tax
17.15%
-16.15
-19.49 -17.34 -17.11 -14.22
Net Income/Loss
17.15%
-16.15
-19.49 -17.34 -17.11 -14.22
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2,259%
48.26
2.0461 43.44 39.29 36.26
Diluted Average Shares
2,259%
48.26
2.0461 43.44 39.29 36.26
Basic Earnings Per Share
17.50%
-0.33
-0.40 -0.40 -0.44 -0.39
Diluted Earnings Per Share
17.50%
-0.33
-0.40 -0.40 -0.44 -0.39
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Kapitalisierung:     |  Volumen (24h):